XML 25 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
Balance Sheets (USD $)
Sep. 30, 2014
Dec. 31, 2013
Current Assets    
Cash $ 613,645 $ 48,589
Prepaid expenses and deposits 30,004 15,004
Deferred financing costs    13,439
Total Current Assets 643,649 77,032
Current Liabilities    
Accounts payable and accrued liabilities 671,016 3,778,401
Research agreement obligations 492,365 492,365
Derivative liability - conversion option    582,300
Derivative liability - warrants 83,521 140,504
Convertible notes payable    3,161,977
Loans payable, related party (2013 - $5,200)    42,200
Promissory notes 52,942 277,942
Due to related parties    369,346
Total Current Liabilities 1,299,844 8,845,035
Stockholders' Deficit    
Convertible preferred stock, $0.001 par value — 10,000,000 shares authorized: Series A, $0.001 par value, 1,250,000 shares designated, -0- shares issued and outstanding as of September 30, 2014 and December 31, 2013      
Convertible preferred stock, $0.001 par value - 10,000,000 shares authorized: Series B, $0.001 par value, 1,500,000 shares designated, -0- shares issued and outstanding as of September 30, 2014      
Common stock, $0.001 par value, 500,000,000 shares authorized 19,603,815 shares issued and outstanding (2013 – 1,465,712) 19,604 1,466
Additional paid-in capital 84,484,316 46,430,750
Shares to be issued 468,675 284,750
Accumulated other comprehensive loss (85,573,221) (55,426,635)
Accumulated deficit (55,569) (58,334)
Total Stockholders' Deficit (656,195) (8,768,003)
Total Liabilities and Stockholders' Deficit $ 643,649 $ 77,032